{"id":"W2596883961","doi":"10.1200/jco.2016.70.7257","title":"Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline","year":2017,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":223,"is_retracted":false,"has_abstract":true,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Medicine; Denosumab; Zoledronic acid; Breast cancer; Guideline; Internal medicine; Oncology; Adjuvant; Adjuvant therapy; Cancer; Clinical trial; Osteonecrosis of the jaw; Bisphosphonate; Osteoporosis; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.01058878,0.0005752499,0.01617399,0.0002031133,0.00008069821,0.00001564138,0.0003144506,0.002210859,0.0001090401],"category_scores_gemma":[0.008545395,0.0003881145,0.002168728,0.000213423,0.001894041,0.0002288617,0.0003043629,0.004760942,0.000002044462],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001045942,"about_ca_system_score_gemma":0.03314182,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.1019344,"about_ca_topic_score_gemma":0.06649996,"domain_scores_codex":[0.9796817,0.002494176,0.01585213,0.0007842034,0.0006242148,0.000563573],"domain_scores_gemma":[0.9580024,0.01202865,0.0264357,0.0005900133,0.001738167,0.001205043],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.004369791,0.00228135,0.3058971,0.001905048,0.002047647,0.0004930947,0.0001780176,6.743794e-7,3.44839e-8,0.000001859091,0.004897088,0.6779283],"study_design_scores_gemma":[0.01027723,0.007978973,0.1534792,0.00722331,0.006502662,0.0009511033,0.0001811739,0.00001868997,5.662565e-8,0.000005346854,0.8131717,0.0002104951],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0307913,0.9576439,0.000003411036,0.007566633,0.00232327,0.001144113,0.0002804189,0.000006806388,0.000240123],"genre_scores_gemma":[0.001297043,0.9764488,0.01426833,0.006812967,0.0008555001,0.00003577126,0.00001699555,0.00007067161,0.0001939688],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8082747,"threshold_uncertainty_score":0.9998571,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.5669481703085816,"score_gpt":0.6544656793088844,"score_spread":0.08751750900030286,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}